First-ever in modern Indian medicine: CSIR DG hails clinical trial nod to test plant-based drug for COVID-19 treatment

New Delhi: Clinical trials of the plant-derived drug, ACQH, to treat COVID-19 patients that began on Friday in India has been hailed by the Council of Scientific and Industrial Research (CSIR) as "historic in modern medicine".

Speaking to ANI, Dr Shekhar Mande, Director General, CSIR said, "CSIR is pleased to inform that ACQH clinical trial has begun yesterday, by Sun Pharmaceutical in collaboration with ICGEB New Delhi and CSIR IIIM Jammu with support by CSIR and DBT. We are going to attempt to combat COVID-19 and we do hope that it is successful." ....read more

CMAAO Coronavirus Facts and Myth Buster 119: HCQ wins

(With inputs from Dr Monica Vasudev)939: Two Journals Retract Studies on HCQ, Heart Disease in COVID-19MEDSCAPE: The Lancet announced that it has retracted a highly cited study that indicated that hydroxychloroquine may cause more harm than benefit in patients with COVID-19.Soon, the New England Journal of Medicine also announced that it has retracted an article by some of the same authors, also on heart disease and COVID-19. ....read more

Sattchittaananda: The soul characteristics

Satt means ‘truth or knowingness’Chitta means ‘consciousness-based’Ananda means ‘bliss or inner happiness’The soul in Vedic description is described as Sattchittaananda. People in touch with their soul speak the truth, take consciousness-based decisions and experience inner happiness. ....read more

Video of The day

FIR on Ganga Ram Hospital under section 154

Healthcare News Monitor

British pharma giant AstraZeneca all set to roll out COVID-19 vaccine in September

The Indian Express

LONDON: British pharma giant AstraZeneca is "on track" to begin rolling out up to two billion doses of a coronavirus vaccine in September if ongoing trials prove successful, its chief executive said on Friday.The company is partnering with Oxford University, which has pioneered the vaccine, and is already manufacturing doses before seeking final regulatory approval once testing concludes in the coming months.

Sun Pharma initiates phase-2 clinical trials for potential COVID-19 treatment drug

Financial Express

Drug major Sun Pharmaceutical Industries on Friday said it has commenced phase-2 clinical trials on AQCH, a plant-derived drug, for potential treatment of COVID-19. The company received approval from the Drugs Controller General of India (DCGI) for conducting the trials of the phytopharmaceutical drug in April this year, Sun Pharma said in a statement.“The clinical trials will be conducted across 12 centres in India on 210 patients. The treatment duration for patients will be 10 days. The results of the clinical trials are expected by October 2020,” it added. Human safety study of AQCH has already been completed and the drug has been found safe at the recommended dose for phase-2 study, Sun Pharma said.

How a remark by a doctor in Wuhan evoked Gandhi’s efforts, why it matters

The Indian Express

Long after our world bids farewell to COVID-19, a sentence uttered quite close to the virus’s birth is likely to be remembered. On January 30, Li Wenliang, a 34-year-old Chinese doctor in Wuhan, said: “I think there should be more than one voice in a healthy society.” On February 7, a day after the Straits Times of Singapore published his remark, Li succumbed, in a Wuhan ICU, to the virus he had tried to cure in others.

‘His Mental Health Remains a Question’: Doctor Finds Mobile Charger in Guwahati Man’s Bladder, Latter Had Used it to Masturbate

India.comZarafshan Shiraz

25 years of experience in surgery and doctor Wallie Islam continues to be surprised and shocked by instances like the recent one where he retrieved a mobile phone charger cord from a Guwahati man’s bladder who had used it to masturbate. The process of insertion was urethral sounding, a type of masturbation term used to describe the act where an object or liquid is inserted into the urethra. Also Read - Prayagraj MNNIT Researcher Develops Low-Cost Portable ECG Device That Can Generate Real-Time Report